CJC‑1295 + Ipamorelin is a combination of two synthetic “growth hormone secretagogues” — injectable peptides that push the pituitary gland to release more of the body’s own growth hormone (GH), rather than supplying GH directly like an hGH injection. It’s typically sold as a single lyophilized vial labeled “for research use only,” and neither compound is an approved medicine.
The blend works on two independent receptor systems in the pituitary: CJC‑1295 activates the GHRH receptor (the hypothalamus’s natural “make GH” signal), while ipamorelin activates the ghrelin receptor (a second, distinct GH‑release trigger). Given together, they amplify each other’s effect, producing a larger GH pulse than either alone while preserving the body’s natural pulsatile rhythm — the theory is a physiologic-range boost in GH and IGF‑1 rather than the flat, supraphysiologic levels you get from injected hGH. Ipamorelin’s selling point is selectivity: unlike older secretagogues (GHRP‑2, GHRP‑6, hexarelin), it raises GH without bumping cortisol, ACTH, prolactin, FSH, LH, or TSH Wikipedia. Vendors pair the short‑acting “no‑DAC” form (Mod GRF 1‑29) with ipamorelin to mimic natural pulses — note that “CJC‑1295” and “Mod GRF 1‑29” are genuinely different molecules that get conflated constantly, even in published papers.
it’s a two-pathway GH secretagogue stack — a long- or short-acting GHRH analog plus a selective ghrelin mimetic — that reliably raises GH/IGF‑1 in humans but never completed drug development, exists today only as an unapproved research product, and is prohibited in competitive sport.
CJC 1295 + Ipamorelin 20MG
Lyophilized Powder, ≥99% Purity
$139.95
Quantity & Discount
CJC-1295 / Ipamorelin Blend is a lyophilized peptide combination containing 10mg of CJC-1295 without DAC (also known as Mod GRF 1-29), a synthetic 29-amino acid growth hormone releasing hormone analog, and 10mg of Ipamorelin, a synthetic 5-amino acid pentapeptide. Molecular weights are 3367.9 g/mol (CJC-1295 no DAC) and 711.9 g/mol (Ipamorelin). Supplied with ≥98% purity per component. For in-vitro research use only. Not for human consumption.
Additional information
| Size | 20MG |
|---|
Within advanced laboratory studies, this GHRH analog has been critically examined for its dynamic interaction with GH pulse frequency and amplitude, offering unparalleled insight into exactly how sustained stimulation directly influences circadian hormonal rhythms and systemic regulatory feedback mechanisms. These well-documented properties heavily support comprehensive comparative research alongside other secretagogues and advanced metabolic research peptides, actively enabling a much broader scientific understanding of complex, hormone-driven physiological processes as documented in prominent endocrinology databases. A defining characteristic of this specific research peptide in a laboratory setting is its highly optimized pharmacokinetic profile. When observing cellular uptake in controlled assays, scientists track how it strongly binds to endogenous albumin, significantly extending its half-life and preventing rapid enzymatic degradation. In cellular models, this translates to a profound shift in prolonged receptor activation. This mechanism is vital for longitudinal studies examining progressive metabolic adaptation, particularly in age-related metabolic decline scenarios where pituitary efficiency naturally wanes. By mapping these pathways, researchers gain a deeper understanding of cellular resilience and endocrine preservation over multi-day observational periods. This premium formulation is supplied as a sterile, lyophilized (freeze-dried) powder, a format specifically selected to support maximum long-term biochemical stability, highly precise handling, and consistent reconstitution under appropriate, rigorous laboratory conditions. The substantial 10mg concentration is exceptionally well suited for extended research protocols, granular dose-variation studies, and highly controlled experimental designs. Applying precise calculations during the reconstitution process ensures reliable molarity across research batches, providing researchers with ultimate flexibility for a remarkably wide range of scientific investigations. To preserve the highly sensitive structural integrity of the amino acid sequence, strict adherence to climate-controlled, cold-chain storage is absolutely mandatory. Once reconstituted with bacteriostatic water, vials should be kept strictly refrigerated between 2°C and 8°C. Maintaining a stable, cold environment ensures that the molecular binding affinity remains completely uncompromised over the duration of a lengthy study. For laboratories looking to cross-reference data, incorporating this compound with other structural variants from our extensive peptide library ensures high-fidelity comparative analyses, which is especially important when managing testing logistics across diverse Canadian regional climates.
Store between 2°C and 8°C. Protect from light. Reconstitute only the amount needed.
CJC-1295 + Ipa (20mg) is provided strictly for laboratory research use only. It is not intended for human or animal consumption, medical treatment, or diagnostic purposes. All use must comply with applicable laboratory regulations and research standards.
For laboratory research use only. Not for human consumption.

